Computational approaches for drug repurposing in oncology: untapped opportunity for high value innovation
Historically, the effort by academia and industry to develop new chemical entities into lifesaving drugs has limited success in meeting the demands of today’s healthcare. Repurposing drugs that are originally approved by the United States Food and Drug Administration or by regulatory authorities aro...
Main Authors: | Shraddha M. Dalwadi, Andrew Hunt, Mark D. Bonnen, Yohannes T. Ghebre |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1198284/full |
Similar Items
-
A Database of Drug Repurposing Clinical Trials in Oncology
by: Pan Pantziarka, et al.
Published: (2021-11-01) -
Repurposing Drugs in Small Animal Oncology
by: Antonio Giuliano, et al.
Published: (2022-12-01) -
The Role of Dopamine in Repurposing Drugs for Oncology
by: Catarina Moura, et al.
Published: (2023-07-01) -
Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies
by: Carlos Pérez-Plasencia, et al.
Published: (2021-06-01) -
Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
by: Rita Rebelo, et al.
Published: (2021-03-01)